US-Guided Serratus Anterior Plane Block Versus Thoracic Epidural in Patients Undergoing Thoracotomy
Lung Cancer, Acute Pain, Chronic Pain
About this trial
This is an interventional treatment trial for Lung Cancer focused on measuring Lung Cancer, Serratus anterior plane block, Thoracic epidural
Eligibility Criteria
Inclusion Criteria: Physical status ASA II and III. Body mass index (BMI): > 20 kg/m2 and < 40 kg/m2. A patient undergoing thoracotomy for cancer surgery (Lobectomy, Pneumonectomy, and Decortication). Exclusion Criteria: Patient refusal Known sensitivity or contraindication to local anesthetics. History of psychological disorders. Localized infection at the site of block. Coagulopathies with a platelet count below 50,000 or an INR>1.5: hereditary (e.g. hemophilia, fibrinogen abnormalities & deficiency of factor II) - acquired (e.g. impaired liver functions with PC less than 60 %, vitamin K deficiency &therapeutic anticoagulants drugs),History of unexplained or easy bruising and Prolonged bleeding from small cuts or after dental procedures. patients need prolonged mechanical ventilation postoperatively excluded from our study. failed blocks will be excluded from our study
Sites / Locations
- National Cancer Institute
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Serratus anterior plane block:
Thoracic Epidural